Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serotonin receptors (5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C) are G protein-coupled receptors that mediate the effects of serotonin in the central and peripheral nervous systems. They regulate a wide range of physiological processes including mood, cognition, pain, appetite, sleep, and more. 5-HT1A/1B are Gi/o coupled, leading to neuronal inhibition, while 5-HT2A/2C are Gq/11 coupled, leading to excitatory responses. Many psychiatric drugs target these receptors to treat depression, anxiety, schizophrenia, and other disorders.
Agonism, partial agonism, antagonism, inverse agonism at serotonin receptor subtypes. Modulation of cAMP and IP3/DAG signaling pathways.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptors 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C (5-HT1A/1B/2A/2C).